How Dietary Supplements Can Be Sold Without FDA Approval

Last updated 5 days ago. Our resources are updated regularly but please keep in mind that links, programs, policies, and contact information do change.

The dietary supplement industry represents one of the biggest paradoxes in American healthcare. It’s a massive market that has exploded from 4,000 products in 1994 to over 80,000 today, with annual sales exceeding $50 billion. Nearly three-quarters of Americans take supplements.

Yet this enormous industry operates under a regulatory framework that most people completely misunderstand. A 2002 poll revealed that most American adults mistakenly believe supplements must be approved by a government agency before sale and must carry warning labels about side effects.

The reality is strikingly different. Unlike prescription drugs, dietary supplements don’t need FDA approval before reaching store shelves. The agency’s role is largely reactive—monitoring for problems after products are already being sold to consumers.

This regulatory gap creates both opportunities and risks. While it allows quick access to potentially beneficial products, it also means that unsafe, contaminated, or ineffective supplements can reach consumers with minimal upfront scrutiny.

Understanding how this system actually works empowers you to navigate the supplement aisle safely and make informed decisions about what you put in your body.

What Counts as a Dietary Supplement

The Legal Definition That Changed Everything

The Dietary Supplement Health and Education Act (DSHEA) of 1994 created the legal blueprint for the entire supplement industry. Congress—not the FDA—defined what counts as a dietary supplement.

To be legally classified as a “dietary supplement,” a product must meet specific criteria:

Intended to supplement the diet: The purpose isn’t to be a conventional food but to add to a person’s dietary intake.

Contains dietary ingredients: This broad category includes vitamins, minerals, herbs, amino acids, enzymes, and other substances.

Intended for ingestion: The product must be swallowed. Topical creams or inhaled products don’t count as dietary supplements.

Labeled as a dietary supplement: The front panel must explicitly identify it as a “dietary supplement” or use similar phrasing.

Not represented as conventional food: The product can’t be marketed as regular food or a meal replacement.

This definition is notable for its breadth. By encompassing everything from simple vitamin tablets to complex herbal blends or synthetic amino acids, the law created an exceptionally vast product category that became the foundation for explosive market growth.

The Universe of Dietary Ingredients

Legally recognized dietary ingredients include:

Vitamins and Minerals: The most familiar supplements like Vitamin C or calcium.

Herbs and Botanicals: Plant-derived products like ginseng, echinacea, or St. John’s wort, plus algae and fungi.

Amino Acids: The building blocks of proteins.

Dietary Substances: A catch-all category including enzymes and probiotics—substances that are part of the food supply.

Concentrates, Metabolites, Constituents, or Extracts: Parts or chemical compounds from the above ingredients, like specific herbal extracts.

Supplement formulations also contain “other ingredients”—fillers, binders, preservatives, sweeteners, and flavorings necessary for manufacturing but not intended to have therapeutic effects.

New Dietary Ingredients: A Critical Distinction

DSHEA created an important distinction between ingredients that were on the market before October 15, 1994, and those that came after.

A “New Dietary Ingredient” (NDI) is any ingredient not sold in the U.S. as a dietary supplement before that date. Companies wanting to market supplements containing NDIs must notify the FDA at least 75 days before introducing the product.

This pre-market notification isn’t a request for approval. Instead, manufacturers must provide evidence they used to conclude the NDI is “reasonably expected to be safe” under recommended use conditions. The FDA reviews this safety information but doesn’t “approve” the ingredient for effectiveness.

Any ingredient already on the market before October 15, 1994, is “grandfathered”—presumed safe without requiring FDA notification. This provision allowed thousands of existing products to remain available without new review, ensuring continued consumer access.

How DSHEA Transformed the Market

The Legislative Backstory

DSHEA became law on October 25, 1994, culminating years of intense debate and grassroots consumer advocacy. In the early 1990s, the FDA had begun taking actions that the supplement industry and consumers feared would lead to over-regulation, potentially classifying many vitamins and herbs as drugs and severely limiting access.

DSHEA was presented as a “common sense” solution to strike a balance—protecting consumer access to safe supplements while empowering personal healthcare choices. The law emphasized documented benefits of supplements in health promotion and disease prevention.

The Pivotal Decision: Supplements as Food, Not Drugs

The most consequential decision in DSHEA was formally classifying dietary supplements as a special category under “foods” rather than drugs. This classification is the bedrock of the entire regulatory system.

By defining supplements as food, DSHEA achieved several key objectives:

Exempted them from rigorous pre-market safety and efficacy evaluations required for new drugs. The immense cost and time of drug approval were deemed an “unreasonable regulatory barrier.”

Clarified that dietary ingredients wouldn’t be regulated as “food additives,” which would have required pre-market safety data submission to the FDA.

Created a post-market surveillance system where FDA oversight begins mainly after products are already for sale.

The FDA’s Limited Role

DSHEA fundamentally limited the FDA’s authority over supplements compared to drugs. The FDA is not authorized to “approve” dietary supplements for safety or effectiveness before marketing.

Except for NDI notifications, companies can lawfully introduce supplements without even notifying the FDA. The agency’s primary role is monitoring the marketplace for problems and taking enforcement action against illegal products.

This creates a critical reversal of the burden of proof. For drugs, manufacturers must prove safety and effectiveness to the FDA. For supplements, the FDA must prove products are “adulterated” (unsafe, contaminated, or prepared under unsanitary conditions) or “misbranded” (improperly labeled or making illegal disease claims) to restrict them.

Market Explosion and Its Consequences

DSHEA’s impact was immediate and profound. Freed from pre-market approval constraints, the industry flourished. The number of available products skyrocketed from around 4,000 in 1994 to over 80,000 today, while annual sales grew from $4 billion to over $50 billion.

However, DSHEA’s success in fostering growth has exposed limitations of its 30-year-old framework. The law predated the internet explosion and didn’t anticipate novel ingredients like CBD or complex probiotic strains.

One significant challenge is that the FDA has no comprehensive list of all supplements currently on the market. A key proposed reform is implementing Mandatory Product Listing, requiring manufacturers to submit basic product information—names, ingredients, and label copies—to provide the agency crucial transparency.

Supplements vs Drugs: Two Different Worlds

One of the biggest sources of public confusion is assuming dietary supplements are regulated like medications. In reality, the government maintains vastly different regulatory pathways for these categories.

Pre-Market vs Post-Market: The Fundamental Divide

Drugs operate under strict pre-market approval. Before new prescription or over-the-counter drugs can be marketed, manufacturers must conduct extensive laboratory, animal, and human clinical trials to generate scientific evidence of safety and effectiveness. This data is submitted in a New Drug Application (NDA) for rigorous FDA review. Only if demonstrated benefits outweigh known risks will approval be granted.

Dietary supplements operate under post-market surveillance. Generally, manufacturers don’t need to provide the FDA any evidence of safety or effectiveness before marketing. Except for NDI notifications, companies can begin selling supplements without FDA review or approval. The FDA monitors for safety problems after products are already being consumed.

The Burden of Proof Difference

For Drugs: Manufacturers bear the burden of proof, responsible for conducting research and proving to the FDA that products are safe and effective.

For Supplements: The FDA bears the burden of proof, requiring the agency to collect evidence and legally prove products are unsafe, contaminated, or illegally marketed to take enforcement action.

When Supplements Become Illegal Drugs

While supplements and drugs occupy separate regulatory worlds, there’s a clear line that transforms a product’s legal status when crossed. A supplement becomes an illegal, unapproved drug if its labeling or advertising makes “disease claims”.

A disease claim is any statement suggesting the product can “diagnose, cure, treat, or prevent a disease.” Only FDA-approved drugs can legally make such claims.

For example, a supplement saying “supports healthy immune system” makes a legal structure/function claim. But if it claimed “prevents the flu” or “treats COVID-19,” it would be making illegal disease claims, subjecting it to enforcement actions.

Manufacturing Standards and Quality Control

Although supplements aren’t subject to pre-market approval, the law doesn’t give manufacturers a free pass. DSHEA places primary legal responsibility for ensuring product safety and quality on manufacturers.

Current Good Manufacturing Practices

The FDA’s most significant tool for ensuring supplement quality is authority to establish and enforce Current Good Manufacturing Practices (cGMPs). While DSHEA authorized these rules in 1994, specific supplement cGMPs weren’t finalized until 2007 and became fully enforceable in 2010.

These regulations apply to all domestic and foreign companies that manufacture, package, label, or hold dietary supplements for U.S. sale. The purpose is establishing controls ensuring supplements are produced consistently and meet established standards for identity, purity, quality, strength, and composition.

Key cGMP requirements include:

Personnel: Employ qualified, trained staff with quality control personnel operating independently from production staff with authority to approve or reject materials and processes.

Physical Plant: Maintain facilities in clean, sanitary conditions to prevent contamination.

Equipment: Properly design, construct, maintain, and calibrate all equipment to ensure proper function without introducing contaminants.

Production Controls: Create master manufacturing records (MMRs)—detailed “recipes” specifying ingredients, weights, and production procedures for each product. Create batch production records (BPRs)—detailed “log books” documenting that MMRs were followed precisely for every batch.

Component Testing: Establish specifications for all components and finished products. Conduct at least one appropriate test to verify identity of every dietary ingredient. Ensure finished products meet specifications for purity, strength, composition, and freedom from contaminants like heavy metals or harmful microbes.

Record-Keeping: Maintain extensive records for every process step, from receiving raw ingredients to distributing final products. Keep records for at least one year past shelf-life or two years past distribution if no shelf-life date exists.

The Quality Gap Problem

While comprehensive cGMP rules represent the government’s primary proactive approach to supplement quality, their effectiveness depends entirely on industry compliance and FDA verification through inspections.

Given the vast number of manufacturers and FDA’s limited resources, inspections aren’t as frequent as for pharmaceutical facilities. Reports indicate a significant percentage of inspected facilities have cGMP violations.

This creates a quality gap between highly compliant companies—which often seek voluntary third-party certifications from organizations like NSF International or USP—and less scrupulous companies operating in violation until inspected, if ever.

Dual Agency Oversight

Supplement regulation involves two federal agencies with distinct roles:

FDA: Responsible for product safety and labeling issues, including cGMP enforcement, actions against adulterated products, and oversight of claims on physical labels and packaging.

FTC: Has primary jurisdiction over product advertising, including claims in print, television, radio, and online. Requires advertising to be truthful, not misleading, and adequately substantiated before running.

Companies must comply with both agencies’ rules. The FDA may find a label compliant while the FTC takes action against the same company for unsubstantiated advertising claims.

Decoding Supplement Labels

For consumers, the product label is the primary information source. Understanding how to read and interpret it is critical for safe supplement navigation.

Label Anatomy

Principal Display Panel (front of bottle):

Statement of Identity: Clearly states what the product is (“Dietary Supplement,” “Vitamin C Supplement,” “Herbal Supplement”).

Net Quantity of Contents: States how much product is in the container (“60 Capsules,” “8 fl oz”).

Information Panel (side or back):

Supplement Facts Panel: Standardized panel unique to supplements listing Serving Size, Servings Per Container, and all dietary ingredients with Amount Per Serving. For vitamins and minerals, often includes % Daily Value (%DV). For botanicals, must state plant part used (root, leaf). For proprietary blends, lists total weight and individual ingredients in descending order by weight.

Other Ingredients: Lists all non-dietary ingredients like fillers, binders, artificial colors, sweeteners, or flavors in descending order by weight.

Manufacturer Information: Name and business location of manufacturer, packer, or distributor.

Directions for Use: Recommended usage instructions.

Three Types of Legal Claims

Claims on supplement labels and marketing create significant consumer confusion. Three main types are legally permitted, each with different rules and FDA scrutiny levels.

Structure/Function Claims

Most common type found on supplement labels. These describe the role of nutrients or dietary ingredients in affecting normal body structure or function, or promoting general well-being.

Examples: “Calcium builds strong bones,” “Fiber maintains bowel regularity,” “Antioxidants maintain cell integrity,” “Helps support healthy joints.”

Rules: Don’t require FDA pre-approval, but manufacturers must have scientific substantiation that claims are truthful and not misleading. Companies must notify FDA of claims within 30 days of first marketing. All structure/function claims must include the mandatory FDA disclaimer.

Nutrient Content Claims

Characterize the level of nutrients in products, often relative to established Daily Values.

Examples: “High potency,” “Good source of Vitamin C,” “High in antioxidants,” “Fat free,” “Reduced sodium.”

Rules: Don’t require pre-approval but are strictly defined by FDA regulations. To claim “good source” of a vitamin, products must contain 10-19% of Daily Value per serving. To be “high” in a vitamin requires 20% or more.

Health Claims

Most powerful and stringently regulated claims. Health claims explicitly link supplement ingredients to reduced risk of specific diseases or health conditions.

Example: “Adequate calcium and vitamin D throughout life, as part of a well-balanced diet, may reduce the risk of osteoporosis.”

Rules: Must be reviewed and authorized by FDA before use. Evaluated based on “Significant Scientific Agreement” standard—strong consensus among qualified experts supported by totality of publicly available scientific evidence. Because this bar is so high, authorized health claims are relatively rare on supplement labels.

A related category, “Qualified Health Claims,” is based on credible but not SSA-standard evidence and must include qualifying language like “Scientific evidence suggests but does not prove…”

The Mandatory Disclaimer

Any structure/function claim on supplement labels must be followed by a specific disclaimer:

“This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.”

This disclaimer informs consumers that: (1) FDA hasn’t independently verified the scientific basis for the claim, and (2) the product is legally a supplement (food), not a drug, and cannot be marketed to treat medical conditions.

Safety Risks and Concerns

While many supplements can be used safely, their unique regulatory status creates potential risks consumers must understand. The marketplace is vast, and quality control varies dramatically between products.

The “Natural” Myth

One of the most dangerous myths is believing that “natural” means “safe.” The term “natural” isn’t regulated by FDA in supplement labeling context and is essentially a marketing term.

Many potent and toxic substances derive from natural sources. Botanical supplements kava and comfrey have been linked to serious liver damage. Plants contain hundreds or thousands of chemical compounds, and extraction processes can concentrate potentially harmful compounds alongside beneficial ones.

Contamination and Adulteration Dangers

A significant public health concern is product contamination and illegal adulteration occurring in two primary ways:

Poor Manufacturing: Due to cGMP failures, products can become contaminated with heavy metals (lead, mercury, arsenic), pesticides, or dangerous microbes like Salmonella or E. coli. Recent FDA alerts highlighted lead in cinnamon products and toxic amygdalin in apricot seeds.

Illegal Drug Adulteration: Unscrupulous manufacturers deliberately “spike” supplements with undeclared pharmaceutical drugs to make products appear effective, deceiving consumers and creating serious health risks. This problem is particularly rampant in three categories:

• Weight Loss Supplements: Frequently tainted with prescription diuretics, banned stimulants like sibutramine, or antidepressants
• Sexual Enhancement Supplements: Commonly adulterated with sildenafil (Viagra), tadalafil (Cialis), or similar synthetic chemicals
• Bodybuilding Supplements: May be illegally spiked with anabolic steroids or dangerous steroid-like substances

The regulatory framework’s lack of pre-market approval and high bar for FDA enforcement creates a “high-risk, high-reward” scenario for bad actors who can quickly launch tainted products, profit significantly, and potentially disappear before FDA identification and action.

Dangerous Drug Interactions

Supplements contain biologically active ingredients that can interact with prescription and over-the-counter medications, sometimes with dangerous or life-threatening consequences. These interactions can alter drug absorption, metabolism, or excretion, making medications dangerously strong or completely ineffective.

Well-documented examples include:

St. John’s Wort: Can accelerate breakdown of many medications, reducing effectiveness of antidepressants, birth control pills, blood thinners (warfarin), and certain cancer medications.

Vitamin K: High doses can counteract blood thinner warfarin effects, making it less effective and increasing dangerous blood clot risk.

Antioxidants (Vitamins C and E): High doses during cancer treatment might interfere with chemotherapy and radiation effectiveness, which rely on oxidative damage to kill cancer cells.

Ginkgo Biloba: Has blood-thinning effects and taking with anticoagulant drugs like aspirin or warfarin can increase uncontrolled bleeding risk.

These potential interactions underscore why patients must inform doctors and pharmacists about every supplement they’re taking.

Medical Professional Perspective

Medical professionals express significant concerns about the supplement market rooted in lack of pre-market safety and efficacy review. From a clinical standpoint, supplements aren’t merely “expensive placebos”—they can have direct physiological effects influencing patient health and interacting with medical treatments.

Physicians are particularly concerned about the “explosion of new ingredients” entering the market since 1994, many with unknown risk profiles and lacking robust scientific study. Medical consensus is that for most healthy individuals, a well-balanced diet provides all necessary nutrients, making widespread supplementation unnecessary.

Supplementation is generally recommended only for specific, diagnosed nutrient deficiencies or certain medical conditions, such as for bariatric surgery patients with altered nutrient absorption. The core medical community message is caution and communication—patients must disclose all supplement use to allow comprehensive risk and benefit evaluation.

When Things Go Wrong: Enforcement and Reporting

Because the FDA’s supplement regulatory system is primarily reactive, enforcement actions and public-reported data are consumer protection cornerstones. When the agency identifies unsafe, contaminated, or illegally marketed products, it has several tools to remove them and hold companies accountable.

FDA Enforcement Tools

Warning Letters: Most common initial action. FDA sends formal letters detailing specific legal and regulatory violations, from significant cGMP failures to illegal disease claims. Companies must take corrective action or face further consequences. FDA publishes these letters online, providing transparent records of non-compliant companies.

Seizure and Injunction: If companies fail to correct violations or products pose significant public health risks, FDA can work with the Department of Justice for legal action, including seizing illegal products or obtaining court-ordered injunctions to stop manufacturing and distribution.

Recalls: FDA can request companies recall dangerous products. While the agency can mandate recalls in certain situations, most supplement recalls are “voluntary”—firms initiate recalls, often after FDA contact about problems. Recalls address issues like undeclared allergens, pathogen contamination, or undeclared drug ingredients.

Import Alerts: For foreign products, FDA can issue import alerts placing products or firms on “red lists,” allowing FDA staff to detain products at borders without physical examination, effectively blocking U.S. market entry.

Your Voice Matters: Reporting Problems

FDA’s ability to identify and act against dangerous products depends heavily on reports from consumers, families, and healthcare professionals. This adverse event reporting system is central to post-market surveillance.

If you believe a supplement caused a serious reaction:

1. Immediately stop taking the product and contact a healthcare professional
2. Report the problem to FDA using the Safety Reporting Portal, providing detailed information including exact product name and manufacturer, lot number, purchase details, and reaction description
3. Report false or misleading advertising to the FTC through their complaint system

Industry Reporting Duties

Under the Dietary Supplement and Nonprescription Drug Consumer Protection Act of 2006, manufacturers, packers, and distributors whose names appear on labels have legal obligations to report information to FDA.

They must submit any “serious adverse event” reports to FDA within 15 business days of receiving them. Serious adverse events result in death, life-threatening experiences, inpatient hospitalization, persistent disability or incapacity, or congenital anomalies. Companies must maintain all adverse event report records for six years.

Your Smart Supplement Toolkit

In a marketplace filled with marketing hype and misinformation, becoming an informed consumer is the best defense. While no online resource replaces personalized consultations with doctors, pharmacists, or registered dietitians, several authoritative sources provide reliable, evidence-based information.

Trusted Government Resources

National Institutes of Health (NIH) Office of Dietary Supplements:

• Dietary Supplement Fact Sheets: Comprehensive, evidence-based fact sheets on hundreds of ingredients from Vitamin A to Zinc, available for both consumers and health professionals
• General Consumer Guide: Excellent overview of understanding supplements

FDA Supplement Information:

• Consumer hub for FDA articles, videos, and updates on supplements
• Problem Reporting Instructions: Direct links to Safety Reporting Portal
• Recalls and Safety Alerts Database: Search official product recalls and safety communications
• Tainted Products List: Running list of products illegally adulterated with hidden drug ingredients

Federal Trade Commission: Information on spotting deceptive advertising and reporting false claims

Nutrition.gov: USDA-sponsored portal to reliable federal nutrition information

MedlinePlus: NIH National Library of Medicine service offering trustworthy health information including comprehensive herbs and supplements section

The Most Important Step: Healthcare Provider Communication

The single most important action any consumer can take to ensure safe, appropriate supplement use is having open, honest conversations with qualified healthcare providers. Your doctor, pharmacist, or registered dietitian is the only one who can provide personalized advice based on your unique health history, medical conditions, and other medications or supplements you’re taking.

This conversation isn’t a substitute for the resources above, but rather the essential context in which all other information should be considered. Healthcare providers can help you:

• Assess whether you actually need supplementation
• Identify potential interactions with your medications
• Recommend high-quality products from reputable manufacturers
• Monitor for adverse effects
• Adjust dosages based on your individual needs

Making Smart Choices

The supplement industry’s rapid growth and limited pre-market oversight place greater responsibility on consumers to make informed decisions. By understanding the regulatory framework, learning to read labels critically, recognizing potential risks, and maintaining open communication with healthcare providers, you can navigate this complex marketplace more safely and effectively.

Remember that supplements are intended to supplement—not replace—a healthy diet and lifestyle. For most people, a balanced diet rich in fruits, vegetables, whole grains, and lean proteins provides the nutrients needed for good health. Supplements may be beneficial for specific deficiencies or medical conditions, but they’re not magic bullets for health problems.

The key to supplement safety lies in being an informed, cautious consumer who verifies claims, researches products, reports problems, and works closely with healthcare providers to make decisions based on individual health needs rather than marketing promises.

Our articles make government information more accessible. Please consult a qualified professional for financial, legal, or health advice specific to your circumstances.